ASTOUND

Serial Number 87768706
606

Registration Progress

Application Filed
Jan 24, 2018
Under Examination
Nov 13, 2018
Approved for Publication
Sep 18, 2018
Published for Opposition
Sep 18, 2018
Registered

Trademark Image

ASTOUND

Basic Information

Serial Number
87768706
Filing Date
January 24, 2018
Published for Opposition
September 18, 2018
Abandonment Date
December 20, 2021
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Dec 20, 2021
Classes
042

Rights Holder

Astellas Pharma Global Development, Inc.

03
Address
1 Astellas Way
Northbrook, IL 60062

Ownership History

Astellas Pharma Global Development, Inc.

Original Applicant
03
Northbrook, IL

Astellas Pharma Global Development, Inc.

Owner at Publication
03
Northbrook, IL

Legal Representation

Attorney
Kathleen Gallagher-Duff

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

38 events
Date Code Type Description
Dec 20, 2021 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Dec 20, 2021 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
May 19, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 18, 2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 18, 2021 EX5G S SOU EXTENSION 5 GRANTED
May 10, 2021 EEXT I SOU TEAS EXTENSION RECEIVED
May 10, 2021 EXT5 S SOU EXTENSION 5 FILED
Oct 30, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 28, 2020 EEXT I SOU TEAS EXTENSION RECEIVED
Oct 28, 2020 EXT4 S SOU EXTENSION 4 FILED
Oct 28, 2020 EX4G S SOU EXTENSION 4 GRANTED
May 13, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 11, 2020 EEXT I SOU TEAS EXTENSION RECEIVED
May 11, 2020 EXT3 S SOU EXTENSION 3 FILED
May 11, 2020 EX3G S SOU EXTENSION 3 GRANTED
Oct 26, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 24, 2019 EEXT I SOU TEAS EXTENSION RECEIVED
Oct 24, 2019 EXT2 S SOU EXTENSION 2 FILED
Oct 24, 2019 EX2G S SOU EXTENSION 2 GRANTED
May 7, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 3, 2019 EEXT I SOU TEAS EXTENSION RECEIVED
May 3, 2019 EXT1 S SOU EXTENSION 1 FILED
May 3, 2019 EX1G S SOU EXTENSION 1 GRANTED
Nov 13, 2018 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 18, 2018 PUBO A PUBLISHED FOR OPPOSITION
Sep 18, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 29, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 16, 2018 ALIE A ASSIGNED TO LIE
Aug 4, 2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 3, 2018 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 3, 2018 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 3, 2018 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
May 7, 2018 CNRT R NON-FINAL ACTION WRITTEN
May 7, 2018 GNRT F NON-FINAL ACTION E-MAILED
May 7, 2018 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 5, 2018 DOCK D ASSIGNED TO EXAMINER
Feb 5, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 27, 2018 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 042
Providing medical and scientific research information in the fields of pharmaceuticals and clinical trials; scientific study and research in the field of pharmaceuticals for prevention of organ transplant rejection
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
042